HIV diagnostics market is driven by increasing incidences of HIV/AIDS across the globe and various governmental initiatives by countries to generate the awareness of HIV in people.HIV Diagnostics Market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 10.07 billion by 2030 and is anticipated to register a CAGR of 10.8%.

The report “HIV Diagnostics Market, By Product (Consumables, Instrument, and Software & Services), By Test Type (Antibody Tests (HIV-1 Screening Tests, HIV-1 Confirmatory Tests and HIV-2 & Group O Diagnostic Tests), Viral Load Tests, CD4 Count Tests, Tests for Early Infant Diagnosis, and Tests for Viral Identification), By End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Others), and Region - Forecast to 2030" 

Key Highlights:

• In November 2022, Abbott has launched ‘Panbio™’ HIV Self Test’ at retail which will increase access to faster, reliable and discrete testing at home. Newly launched self test kit is a finger-stick blood test which helps in detecting HIV-1 and HIV-2 antibodies within 15 to 20 minutes. ‘Panbio™’ HIV Self Test’ is reliable and highly accurate.
• In August 2022, Molbio Diagnostics has launched new ‘Truenat’ RT-PCR test for HIV. Newly launched ‘Truenat’ is a portable, battery operated, and IoT enabled Real Time PCR platform which provides result in less than one hour.
• In April 2021, Altona Diagnostics has launched new ‘AltoStar HIV RT-PCR Kit 1.5’ which is based on RT-PCR technology and used for detection & quantification of HIV-1 in human EDTA plasma. Newly launched test kit will help in allowing amplification of separate regions of HIV-1 genome for monitoring HIV infected patients.

Key Market Insights from the report:          

HIV Diagnostics Market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 10.07 billion by 2030 and is anticipated to register a CAGR of 10.8% . The market report has been segmented on the basis of product, test type, end user and region.

• By product, HIV diagnosis market is segmented into consumables, instrument, and software and services.
• By test type, HIV diagnosis market is segmented into antibody tests, viral load tests, CD4 count tests, test for early infant diagnosis, and tests for viral identification.
• By end user, HIV diagnosis market is segmented into diagnostic laboratories, hospitals, Blood Banks, Home Care Settings and Others.

• By region, North America region accounted major share in HIV diagnostics market. This is owing to factors such as Supportive government initiatives and funding for increasing HIV diagnosis procedures and creating awareness among the population.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “HIV Diagnostics Market”, By Product (Consumables, Instrument, and Software & Services), By Test Type (Antibody Tests (HIV-1 Screening Tests, HIV-1 Confirmatory Tests and HIV-2 & Group O Diagnostic Tests), Viral Load Tests, CD4 Count Tests, Tests for Early Infant Diagnosis, and Tests for Viral Identification), By End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- forecast till 2030"

The prominent player operating in the HIV diagnostics market include Cepheid, BD Biosciences, Roche Diagnostics, Zyomyx Incorporation, Merck & Co., Inc., Bristol –Myres Squibb, Johnson & Johnson, Hologic Incorporation, Chembio Diagnostic Systems, and Abbott Laboratories.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com